Drug-labels.com

Teva-Donepezil: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
5 mg, 10 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Teva-Donepezil

ABOUT THIS MEDICATION

What the medication is used for:

This medicine is called TEVA-DONEPEZIL (which contains donepezil hydrochloride).

Donepezil hydrochloride is one of a group of drugs called “cholinesterase inhibitors”

TEVA-DONEPEZIL is used for the symptomatic treatment of mild, moderate, and severe Alzheimer’s disease.

TEVA-DONEPEZIL can only be obtained with a prescription from a doctor.

What it does:

In the brains of persons with Alzheimer’s disease, there is a decrease in the function of a neurotransmitter system which uses acetylcholine as its chemical messenger. TEVA-DONEPEZIL acts by inhibiting an enzyme called acetylcholinesterase, leading to an increase in the level of acetylcholine in the brain, which may help relieve the symptoms of Alzheimer’s disease.

In clinical studies, patients treated with TEVA-DONEPEZIL showed improvement, remained unchanged, or declined more slowly as compared to patients who received a placebo (sugar tablet). Benefits were seen in memory and other mental functions, as well as in the ability to perform daily activities. TEVA-DONEPEZIL may take as long as 12 weeks to begin working, and patient response to this medicine will vary.

When it should not be used:

If you are allergic to this medicine, any of its inactive ingredients (see the section “What the important nonmedicinal ingredients are”), or to piperidine derivatives such as Mycobutin (rifabutin), Ritalin (methylphenidate), Akineton (biperiden HCl), trihexyphenidyl, bupivacaine, and Paxil (paroxetine HCl).

What the medicinal ingredient is:

TEVA-DONEPEZIL contains donepezil hydrochloride.

What the important nonmedicinal ingredients are:

TEVA-DONEPEZIL Tablets contain the following nonmedicinal ingredients; hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinised starch, talc and titanium dioxide. The 10 mg tablets also contain iron oxide yellow as a colourant.

What dosage forms it comes in:

The 5 mg tablets are white and 10 mg tablets are yellow.

WARNINGS AND PRECAUTIONS

Tell your doctor if you have any muscle pain, tenderness, soreness or weakness, especially if you also have a fever, during treatment with TEVA-DONEPEZIL.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom/effectTalk with your doctor or pharmacistStop taking drug and seek immediate medical help
Only if severeIn all cases
RareRhabdomyolysis: combination of muscle pain, tenderness, or weakness, or joint pain accompanied by a fever or very dark urine that you cannot explainX
Very RareNeuroleptic Malignant Syndrome: A state of high fever, muscle stiffness, irregular blood pressure, pulse and or heartbeats, altered consciousnessX

BEFORE you use TEVA-DONEPEZIL talk to your doctor or pharmacist if:

  • You are taking other medicines, including prescription drugs or products that you can buy without a prescription, such as herbal (natural) products.
  • You have a condition affecting your heart, kidney, liver or your lungs, such as asthma or obstructive pulmonary disease.
  • You have had seizures.
  • You have had fainting spells.
  • You have a history of peptic ulcers or have an increased risk of developing ulcers (for example, if you are taking
  • non-steroidal anti-inflammatory drugs [NSAIDS] or high doses of acetylsalicylic acid [ASA] [Aspirin®]).
  • If you are pregnant or breastfeeding.

  • An operation with a general anesthetic is needed, inform your doctor about the use TEVA-DONEPEZIL.

PROPER USE OF THIS MEDICATION

This medication should only be taken after proper diagnosis of your condition has been made by your doctor.

  • In order to obtain the best results from TEVA-DONEPEZIL, it must be taken every day, exactly as prescribed by your doctor. Never change the dose yourself.
  • Take TEVA-DONEPEZIL once daily, at the same time every day, in the morning or evening.
  • Take TEVA-DONEPEZIL with or without food.

    TEVA-DONEPEZIL tablets should be swallowed whole with water.

    A Reminder: This medicine has been prescribed only for you or for the person you are caring for. Never give it to anyone else.

Overdose:

If more medication has been taken than what has been prescribed, contact either your doctor, hospital emergency department or the nearest poison control center immediately.

Missed Dose:

If you miss taking a dose of TEVA-DONEPEZIL do not worry, just take the next dose when it is due. Do NOT take 2 doses at once.

If you have problems remembering to take medications, it may be necessary to have someone help you.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Along with its beneficial effect, TEVA-DONEPEZIL may cause some undesirable reactions. The most common side effects include nausea (feeling sick) and diarrhea. In clinical studies, these effects were often mild, and generally went away with continued treatment. If they persist you should tell your doctor.

Other possible side effects include:

  • insomnia (difficulty sleeping)
  • vomiting (being sick)
  • muscle cramps
  • fatigue
  • anorexia (loss of appetite)
  • fainting

    If you feel unwell in any other way or have any symptoms that you do not understand, or find distressing, you should contact your doctor immediately. If you experience severe adverse events, stop taking the drug until you can discuss your symptoms with your doctor.

    This is not a complete list of side effects. For any unexpected effects while taking TEVA-DONEPEZIL, contact your doctor or pharmacist.

HOW TO STORE IT

Keep this medicine in a safe place, out of reach of children.

Keep TEVA-DONEPEZIL tablets in a cool dry place (15 to 25°C) and protect from moisture. Keep container tightly closed.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Teva Canada Limited, at:

1-800-268-4127 ext. 1255005 (English)

1-877-777-9117 (French)

or druginfo@tevacanada.com

Reporting Side Effects

You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information.

3 ways to report:

  • Online at MedEffect;
  • By calling 1-866-234-2345 (toll-free);
  • By completing a Consumer Side Effect Reporting Form and sending it by:

    -Fax to 1-866-678-6789 (toll-free), or

    -Mail to: Canada Vigilance Program

    Health Canada, Postal Locator 0701E Ottawa, ON

    K1A 0K9

Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffect.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Teva Canada Limited

30 Novopharm Court

Toronto, Ontario

M1B 2K9

Canada

Last revised: February 3, 2016

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02340607

Revision date stated in the text: February 3, 2016

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Teva-Donepezil

Rx or OTC
Prescription (Rx)?
DIN 02340607, 02340615
Schedule(s) PRESCRIPTION
Active ingredient(s) Donepezil hydrochloride
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06D Anti-dementia drugs
        1. N06DA Anticholinesterase anti-dementia drugs
          1. N06DA02 Donepezil
Company TEVA CANADA LIMITED
Current status Marketed
Current status date December 27, 2013
Strengths and forms
DIN Strength Dosage form(s) Current status
02340607 5 MG Tablet Marketed December 27, 2013
02340615 10 MG Tablet Marketed December 27, 2013

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.